- Home
- Poultry
- Meat
- Pork
- Feed
- Countries
- South Asia News
Japfa, via its biotech subsidiary Vaksindo, is building a vaccine manufacturing facility in Vietnam’s Hung Yen province. The USD 30 million facility will use advanced technology from Japan and Germany to produce vaccines against AI, PRRS, CSF, and FMD. Construction began in early 2022 and is now in ...
Sign in as a member, or Join our Community for free to unlock the full article.
- Indonesia News
Japfa, via its biotech subsidiary Vaksindo, is building a vaccine manufacturing facility in Vietnam’s Hung Yen province. The USD 30 million facility will use advanced technology from Japan and Germany to produce vaccines against AI, PRRS, CSF, and FMD. Construction began in early 2022 and is now in ...
Sign in as a member, or Join our Community for free to unlock the full article.
- Malaysia News
Japfa, via its biotech subsidiary Vaksindo, is building a vaccine manufacturing facility in Vietnam’s Hung Yen province. The USD 30 million facility will use advanced technology from Japan and Germany to produce vaccines against AI, PRRS, CSF, and FMD. Construction began in early 2022 and is now in ...
Sign in as a member, or Join our Community for free to unlock the full article.
- Philippines News
Japfa, via its biotech subsidiary Vaksindo, is building a vaccine manufacturing facility in Vietnam’s Hung Yen province. The USD 30 million facility will use advanced technology from Japan and Germany to produce vaccines against AI, PRRS, CSF, and FMD. Construction began in early 2022 and is now in ...
Sign in as a member, or Join our Community for free to unlock the full article.
- Singapore News
Japfa, via its biotech subsidiary Vaksindo, is building a vaccine manufacturing facility in Vietnam’s Hung Yen province. The USD 30 million facility will use advanced technology from Japan and Germany to produce vaccines against AI, PRRS, CSF, and FMD. Construction began in early 2022 and is now in ...
Sign in as a member, or Join our Community for free to unlock the full article.
- Thailand News
Japfa, via its biotech subsidiary Vaksindo, is building a vaccine manufacturing facility in Vietnam’s Hung Yen province. The USD 30 million facility will use advanced technology from Japan and Germany to produce vaccines against AI, PRRS, CSF, and FMD. Construction began in early 2022 and is now in ...
Sign in as a member, or Join our Community for free to unlock the full article.
- Vietnam News
Japfa, via its biotech subsidiary Vaksindo, is building a vaccine manufacturing facility in Vietnam’s Hung Yen province. The USD 30 million facility will use advanced technology from Japan and Germany to produce vaccines against AI, PRRS, CSF, and FMD. Construction began in early 2022 and is now in ...
Sign in as a member, or Join our Community for free to unlock the full article.
- China News
Japfa, via its biotech subsidiary Vaksindo, is building a vaccine manufacturing facility in Vietnam’s Hung Yen province. The USD 30 million facility will use advanced technology from Japan and Germany to produce vaccines against AI, PRRS, CSF, and FMD. Construction began in early 2022 and is now in ...
Sign in as a member, or Join our Community for free to unlock the full article.
- Home
- Poultry
- Meat
- Pork
- Feed
- Countries
- South Asia News
Japfa, via its biotech subsidiary Vaksindo, is building a vaccine manufacturing facility in Vietnam’s Hung Yen province. The USD 30 million facility will use advanced technology from Japan and Germany to produce vaccines against AI, PRRS, CSF, and FMD. Construction began in early 2022 and is now in ...
Sign in as a member, or Join our Community for free to unlock the full article.
- Indonesia News
Japfa, via its biotech subsidiary Vaksindo, is building a vaccine manufacturing facility in Vietnam’s Hung Yen province. The USD 30 million facility will use advanced technology from Japan and Germany to produce vaccines against AI, PRRS, CSF, and FMD. Construction began in early 2022 and is now in ...
Sign in as a member, or Join our Community for free to unlock the full article.
- Malaysia News
Japfa, via its biotech subsidiary Vaksindo, is building a vaccine manufacturing facility in Vietnam’s Hung Yen province. The USD 30 million facility will use advanced technology from Japan and Germany to produce vaccines against AI, PRRS, CSF, and FMD. Construction began in early 2022 and is now in ...
Sign in as a member, or Join our Community for free to unlock the full article.
- Philippines News
Japfa, via its biotech subsidiary Vaksindo, is building a vaccine manufacturing facility in Vietnam’s Hung Yen province. The USD 30 million facility will use advanced technology from Japan and Germany to produce vaccines against AI, PRRS, CSF, and FMD. Construction began in early 2022 and is now in ...
Sign in as a member, or Join our Community for free to unlock the full article.
- Singapore News
Japfa, via its biotech subsidiary Vaksindo, is building a vaccine manufacturing facility in Vietnam’s Hung Yen province. The USD 30 million facility will use advanced technology from Japan and Germany to produce vaccines against AI, PRRS, CSF, and FMD. Construction began in early 2022 and is now in ...
Sign in as a member, or Join our Community for free to unlock the full article.
- Thailand News
Japfa, via its biotech subsidiary Vaksindo, is building a vaccine manufacturing facility in Vietnam’s Hung Yen province. The USD 30 million facility will use advanced technology from Japan and Germany to produce vaccines against AI, PRRS, CSF, and FMD. Construction began in early 2022 and is now in ...
Sign in as a member, or Join our Community for free to unlock the full article.
- Vietnam News
Japfa, via its biotech subsidiary Vaksindo, is building a vaccine manufacturing facility in Vietnam’s Hung Yen province. The USD 30 million facility will use advanced technology from Japan and Germany to produce vaccines against AI, PRRS, CSF, and FMD. Construction began in early 2022 and is now in ...
Sign in as a member, or Join our Community for free to unlock the full article.
- China News
Japfa, via its biotech subsidiary Vaksindo, is building a vaccine manufacturing facility in Vietnam’s Hung Yen province. The USD 30 million facility will use advanced technology from Japan and Germany to produce vaccines against AI, PRRS, CSF, and FMD. Construction began in early 2022 and is now in ...
Sign in as a member, or Join our Community for free to unlock the full article.
ASIAN AGRIBUSINESS MEDIA PTE LTD